KSCM
KALA icon

Kamunting Street Capital Management’s KALA BIO KALA Stock Holding History

Kamunting Street Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8
Closed -$159K – 89
2020
Q3 		$159K Buy
+8
New +$184K 0.1% 46

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kamunting Street Capital Management's KALA Position: Q4 2020 in Review

Kamunting Street Capital Management sold out of KALA BIO (KALA) in Q4 2020, closing a stake of 8 shares — an estimated $159K sold.

Kamunting Street Capital Management first reported a position in KALA in Q3 2020 and held it in 1 quarter. The position peaked at $159K in Q3 2020. 112 funds tracked by Wall St. Rank hold KALA as of Q4 2020.

  • Kamunting Street Capital Management reported no remaining KALA BIO position as of Q4 2020 after selling out during the quarter.
  • Kamunting Street Capital Management sold 8 KALA BIO shares in Q4 2020, an estimated $159K.
  • Kamunting Street Capital Management first reported a position in KALA BIO in Q3 2020 and held it in 1 quarter.
  • Kamunting Street Capital Management's KALA BIO position peaked at $159K in Q3 2020.
  • 112 funds tracked by Wall St. Rank held KALA BIO as of Q4 2020.

Based on Kamunting Street Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.